lobbying_activities: 2826335

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2826335	dd556bd0-0b29-4ae4-a0d0-15bce8d00c8d	Q2	NATIONAL ORGANIZATION FOR RARE DISORDERS, INC. (NORD)	28264	NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NORD)	2022	second_quarter	PHA	Pharmaceutical issues impacting patients with rare diseases. Orphan Drug Act. User Fee Agreements. Prescription Drug User Fee Act (PDUFA) Reauthorization.	Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE		40000	0	0	2022-07-18T19:26:39-04:00